ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 204 participants.
Also called NCT04503395
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 204 participants
- Sponsor
- Registry
-
NCT04503395
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Austria, Belgium, France, Germany, Italy, Netherlands, Poland, Spain, Switzerland
- Registry status
- Recruiting
Technical summary
Registry record NCT04503395. Randomized; no masking; primary purpose treatment. Start 2021-05-21 (actual); primary completion 2026-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- Acronym
- SOCRATES
- Condition
- Aortic Aneurysm, Abdominal
- Intervention (Device)
- ESAR treatment: Endograft + Heli-FX Endoanchor
- Intervention (Device)
- FEVAR treatment : Fenestrated endograft
- Lead sponsor
- FCRE (Foundation for Cardiovascular Research and Education)
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct04503395- Content hash
f9d33c9f025a75ff76be2a0b2238b0de6dce327f3e627811d6956fe11a220dbf